Optimal dosing interval of intravenous Colistin monotherapy versus combination therapy: A systematic review and meta-analysis
We aimed to maximize the clinical response and effectiveness of colistin antibiotics in patients with multi-drug (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria, there is an increasing interest in colistin combination therapy with other antibiotics and extended interval dosing reg...
Main Authors: | Forouzan Ahmadpour, Elnaz Shaseb, Mandana Izadpanah, Amin Rakhshan, Farzaneh Hematian |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2022-10-01
|
Series: | European Journal of Translational Myology |
Subjects: | |
Online Access: | https://www.pagepressjournals.org/index.php/bam/article/view/10833 |
Similar Items
-
Investigation of Colistin Heteroresistance and Some Factors Affecting Heteroresistance in Carbapenem-Resistant A. baumannii Strains
by: Deniz GAZEL, et al.
Published: (2017-12-01) -
Comparative effectiveness and mortality of colistin monotherapy versus colistin-fosfomycin combination therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections: A propensity score analysis
by: Wasan Katip, et al.
Published: (2024-05-01) -
Combination Regimens with Colistin Sulfate versus Colistin Sulfate Monotherapy in the Treatment of Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli
by: Min Hao, et al.
Published: (2022-10-01) -
Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study
by: Rujipas Sirijatuphat, et al.
Published: (2022-11-01) -
Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
by: Wasan Katip, et al.
Published: (2022-06-01)